Fudan Zhangjiang: Fudan Zhangjiang Voluntary Disclosure Notice on Acceptance of Drug Marketing Applications for Obecholic Acid Tablets to Treat Primary Biliary Cholangitis

SZSI · Nov 1

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.